CareDx (CDNA) Financials

$19.16 +0.26 (+1.38%)

Closing price 04/15/2025 04:00 PM Eastern

Extended Trading

$19.02 -0.15 (-0.76%)

As of 04/15/2025 04:29 PM Eastern

Annual Income Statements for CareDx

This table shows CareDx's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	0.78	-14	-39	-55	-47	-22	-19	-31	-77	-190	53
Consolidated Net Income / (Loss)	0.78	-14	-40	-56	-47	-22	-19	-31	-77	-190	53
Net Income / (Loss) Continuing Operations	0.78	-14	-40	-56	-47	-22	-19	-31	-77	-190	53
Total Pre-Tax Income	-0.72	-14	-41	-57	-48	-24	-20	-32	-76	-190	53
Total Operating Income	1.25	-12	-37	-20	-16	-25	-23	-30	-77	-203	41
Total Gross Profit	19	18	20	27	44	82	129	199	210	178	224
Total Revenue	27	28	41	48	77	127	192	296	322	280	334
Operating Revenue	27	28	41	48	77	127	192	296	322	280	334
Total Cost of Revenue	8.54	10	21	21	33	45	63	97	112	102	110
Operating Cost of Revenue	8.54	10	21	21	33	45	63	97	112	102	110
Total Operating Expenses	18	30	57	47	59	106	152	229	287	382	183
Selling, General & Admin Expense	8.44	12	21	20	23	37	49	75	100	118	124
Marketing Expense	6.47	8.35	11	13	22	39	54	77	96	83	82
Research & Development Expense	3.85	9.33	12	12	15	31	49	77	90	82	72
Restructuring Charge	-	-	-	-	-	-	-	0.00	0.00	2.32	1.78
Other Special Charges / (Income)	-1.24	-0.13	-0.46	-	-	-	-	0.00	0.00	96	-96
Total Other Income / (Expense), net	-1.97	-1.78	-4.03	-37	-33	0.59	2.78	-2.36	1.00	13	12
Interest & Investment Income	-	-1.59	-1.86	-5.86	-3.70	0.99	0.27	0.16	3.76	12	12
Other Income / (Expense), net	0.15	-0.19	-2.17	-31	-23	-0.40	2.51	-2.52	-2.77	1.35	0.33
Income Tax Expense	-1.50	0.00	-1.61	-1.71	-1.43	-1.98	-1.04	-1.43	0.38	0.14	0.31
Basic Earnings per Share	$0.13	($1.16)	($2.39)	($2.38)	($1.31)	($0.52)	($0.40)	($0.59)	($1.44)	($3.54)	$1.00
Weighted Average Basic Shares Outstanding	5.82M	11.86M	16.50M	23.33M	35.64M	42.15M	46.48M	52.24M	53.32M	53.76M	52.77M
Diluted Earnings per Share	$0.10	($1.16)	($2.39)	($2.38)	($1.31)	($0.52)	($0.40)	($0.59)	($1.44)	($3.54)	$0.93
Weighted Average Diluted Shares Outstanding	9.28M	11.86M	16.50M	23.33M	35.64M	42.15M	46.48M	52.24M	53.32M	53.76M	56.62M
Weighted Average Basic & Diluted Shares Outstanding	6M	11.80M	16.50M	23.30M	35.70M	42.88M	51.82M	53.03M	53.67M	51.78M	55.43M

This table shows CareDx's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	-17	-18	-24	-25	-23	-118	-17	-1.39	-7.41	78
Consolidated Net Income / (Loss)	-17	-18	-24	-25	-23	-118	-17	-1.39	-7.41	78
Net Income / (Loss) Continuing Operations	-17	-18	-24	-25	-23	-118	-17	-1.39	-7.41	78
Total Pre-Tax Income	-17	-18	-24	-25	-24	-118	-17	-1.37	-7.21	78
Total Operating Income	-17	-19	-24	-28	-29	-123	-19	-4.10	-10	75
Total Gross Profit	51	53	51	44	43	40	46	64	55	58
Total Revenue	79	82	77	70	67	66	72	92	83	87
Operating Revenue	79	82	77	70	67	66	72	92	83	87
Total Cost of Revenue	28	29	26	26	25	26	26	28	28	28
Operating Cost of Revenue	28	29	26	26	25	26	26	28	28	28
Total Operating Expenses	68	72	76	72	71	163	65	68	66	-16
Selling, General & Admin Expense	24	25	28	29	34	27	27	28	29	41
Marketing Expense	22	24	23	22	18	20	20	21	20	21
Research & Development Expense	22	24	24	20	19	18	19	20	17	17
Total Other Income / (Expense), net	0.67	0.96	0.70	2.60	5.22	4.70	2.60	2.73	3.28	3.49
Interest & Investment Income	1.23	1.87	2.67	2.87	3.17	3.16	2.89	2.83	3.00	3.05
Other Income / (Expense), net	-0.56	-0.91	-1.97	-0.27	2.05	1.54	-0.29	-0.10	0.28	0.44
Income Tax Expense	0.27	0.17	0.12	-0.07	-0.08	0.17	-0.08	0.02	0.20	0.17
Basic Earnings per Share	($0.32)	($0.34)	($0.44)	($0.46)	($0.43)	($2.21)	($0.32)	($0.03)	($0.14)	$1.49
Weighted Average Basic Shares Outstanding	53.49M	53.32M	53.64M	53.85M	54.18M	53.76M	51.69M	52.20M	52.90M	52.77M
Diluted Earnings per Share	($0.32)	($0.34)	($0.44)	($0.46)	($0.43)	($2.21)	($0.32)	($0.03)	($0.14)	$1.42
Weighted Average Diluted Shares Outstanding	53.49M	53.32M	53.64M	53.85M	54.18M	53.76M	51.69M	52.20M	52.90M	56.62M
Weighted Average Basic & Diluted Shares Outstanding	53.54M	53.67M	53.79M	54.17M	54.10M	51.78M	52.08M	52.74M	53.63M	55.43M

This table details how cash moves in and out of CareDx's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	31	-6.54	-13	8.97	38	-25	96	214	-258	-7.66	32
Net Cash From Operating Activities	-3.35	-9.75	-17	-14	-4.01	-2.77	33	-19	-25	-18	38
Net Cash From Continuing Operating Activities	-3.35	-9.75	-17	-14	-4.01	-2.77	33	-19	-25	-18	38
Net Income / (Loss) Continuing Operations	0.78	-14	-40	-56	-47	-22	-19	-31	-77	-190	53
Consolidated Net Income / (Loss)	0.78	-14	-40	-56	-47	-22	-19	-31	-77	-190	53
Depreciation Expense	0.51	0.80	2.92	3.73	4.22	5.52	7.01	8.80	12	14	14
Amortization Expense	0.07	0.12	4.03	3.87	2.47	1.62	2.54	4.22	4.80	0.51	6.18
Non-Cash Adjustments To Reconcile Net Income	-1.19	1.34	15	34	36	22	25	40	48	48	66
Changes in Operating Assets and Liabilities, net	-3.53	1.70	1.02	0.05	0.15	-10	18	-42	-13	109	-101
Net Cash From Investing Activities	-1.33	-1.20	-21	-6.11	-7.93	-23	-100	48	-229	40	-0.48
Net Cash From Continuing Investing Activities	-1.33	-1.20	-21	-6.11	-7.93	-23	-100	48	-229	40	-0.48
Purchase of Property, Plant & Equipment	-0.73	-1.20	-0.55	-0.19	-2.04	-2.20	-7.11	-14	-21	-8.34	-6.48
Acquisitions	-0.60	-	0.00	-5.92	-5.89	-20	-3.25	-22	-3.71	-7.58	0.00
Purchase of Investments	-	-	-	-	0.00	0.00	-90	-5.50	-315	-202	-161
Sale and/or Maturity of Investments	-	-	-	-	-	0.00	0.00	89	112	258	167
Net Cash From Financing Activities	36	4.41	25	29	50	-0.13	163	186	-4.54	-30	-5.61
Net Cash From Continuing Financing Activities	36	4.41	25	29	50	-0.13	163	186	-4.54	-30	-5.61
Repurchase of Common Equity	-3.73	-	-	-	-	-	0.00	0.00	-0.64	-28	-0.52
Issuance of Common Equity	39	0.20	8.23	18	53	0.76	160	191	2.23	1.50	1.40
Other Financing Activities, net	0.02	0.05	0.02	1.25	12	-0.72	3.83	-5.29	-6.12	-3.56	-6.48
Effect of Exchange Rate Changes	0.00	0.00	-	-	0.00	-	0.27	-0.30	0.02	-0.11	0.53
Cash Interest Paid	1.21	1.36	0.87	3.27	1.77	0.02	0.01	0.00	0.01	0.00	0.00
Cash Income Taxes Paid	-	-	-	-	0.00	0.00	0.08	0.01	0.39	0.74	0.32

This table details how cash moves in and out of CareDx's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-84	7.29	-15	13	-12	6.22	11	2.49	-0.38	19
Net Cash From Operating Activities	-7.08	7.19	0.67	-0.50	-10	-8.38	-15	19	13	22
Net Cash From Continuing Operating Activities	-7.08	7.19	0.67	-0.50	-10	-8.38	-15	19	13	22
Net Income / (Loss) Continuing Operations	-17	-18	-24	-25	-23	-118	-17	-1.39	-7.41	78
Consolidated Net Income / (Loss)	-17	-18	-24	-25	-23	-118	-17	-1.39	-7.41	78
Depreciation Expense	3.03	3.21	3.43	3.67	3.66	3.63	3.82	3.54	3.47	3.36
Amortization Expense	1.75	0.69	0.56	-0.00	0.05	-0.10	2.85	0.78	1.78	0.77
Non-Cash Adjustments To Reconcile Net Income	12	13	16	13	11	8.50	13	13	14	26
Changes in Operating Assets and Liabilities, net	-6.67	8.55	4.78	8.15	-1.34	98	-19	2.85	0.99	-87
Net Cash From Investing Activities	-76	2.48	-15	15	-1.50	41	28	-12	-14	-2.11
Net Cash From Continuing Investing Activities	-76	2.48	-15	15	-1.50	41	28	-12	-14	-2.11
Purchase of Property, Plant & Equipment	-4.85	-3.28	-2.77	-2.36	-1.62	-1.59	-1.49	-1.79	-1.69	-1.52
Purchase of Investments	-101	-32	-86	-49	-58	-9.03	-58	-35	-50	-18
Sale and/or Maturity of Investments	31	37	79	67	61	52	87	26	37	17
Net Cash From Financing Activities	-1.03	-2.37	-1.14	-1.57	-0.03	-27	-1.28	-4.85	1.42	-0.90
Net Cash From Continuing Financing Activities	-1.03	-2.37	-1.14	-1.57	-0.03	-27	-1.28	-4.85	1.42	-0.90
Other Financing Activities, net	-2.26	-1.73	-0.90	-1.50	-0.25	-0.91	-1.29	-4.85	0.56	-0.90
Effect of Exchange Rate Changes	-0.03	-0.00	-0.03	-0.09	-0.11	0.11	0.03	0.02	0.08	0.41

This table presents CareDx's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	61	56	77	84	131	152	369	567	543	467	491
Total Current Assets	40	34	27	27	81	72	273	433	388	314	352
Cash & Equivalents	36	30	17	17	65	38	135	348	90	82	115
Short-Term Investments	-	-	-	-	-	0.00	90	0.00	203	153	146
Accounts Receivable	2.69	2.37	2.77	2.99	9.76	24	35	60	66	51	65
Inventories, net	0.69	0.77	5.46	5.53	4.94	6.01	10	17	19	19	20
Prepaid Expenses	0.54	1.34	1.19	1.35	1.80	3.63	3.76	7.93	9.22	7.76	7.07
Plant, Property, & Equipment, net	1.97	2.43	2.93	2.08	0.00	0.00	0.00	0.00	0.00	35	34
Total Noncurrent Assets	19	19	47	55	50	80	95	133	155	118	106
Goodwill	12	12	14	12	12	24	24	37	38	40	40
Intangible Assets	6.65	6.65	33	33	33	46	44	50	43	46	38
Other Noncurrent Operating Assets	0.17	0.20	0.02	-	4.13	10	27	46	74	31	27
Other Noncurrent Nonoperating Assets	-	-	0.14	9.58	0.19	0.26	0.27	0.21	0.52	0.59	0.59
Total Liabilities & Shareholders' Equity	61	56	77	84	131	152	369	567	543	467	491
Total Liabilities	20	26	57	90	35	53	91	101	112	205	113
Total Current Liabilities	11	10	41	43	20	35	69	77	76	78	89
Accounts Payable	1.13	1.64	3.07	3.39	4.71	5.51	9.65	13	9.94	13	7.69
Accrued Expenses	1.86	3.13	5.58	3.74	5.64	17	21	38	49	45	43
Current Employee Benefit Liabilities	1.68	2.37	3.85	5.01	9.16	12	18	26	17	20	38
Total Noncurrent Liabilities	8.71	16	16	47	15	18	22	23	36	127	23
Noncurrent Deferred & Payable Income Tax Liabilities	-	0.00	6.06	4.93	2.97	1.97	1.30	0.42	0.00	0.14	0.16
Other Noncurrent Operating Liabilities	1.10	0.98	6.92	22	12	16	20	23	36	127	23
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	41	29	20	-5.95	96	99	278	466	431	261	378
Total Preferred & Common Equity	41	29	19	-6.13	96	99	278	466	431	261	378
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	41	29	19	-6.13	96	99	278	466	431	261	378
Common Stock	201	203	236	264	412	438	632	854	899	947	1,013
Retained Earnings	-159	-173	-213	-268	-312	-334	-353	-383	-460	-678	-626
Accumulated Other Comprehensive Income / (Loss)	-	0.00	-3.66	-2.35	-4.28	-5.21	-2.10	-4.67	-7.50	-6.96	-8.57

This table presents CareDx's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	545	528	515	501	452	467	477
Total Current Assets	388	371	361	345	303	321	334
Cash & Equivalents	83	75	88	76	93	96	95
Short-Term Investments	208	211	195	192	123	133	145
Accounts Receivable	70	59	52	52	60	66	67
Inventories, net	18	18	19	18	20	19	19
Prepaid Expenses	8.37	8.16	7.68	7.31	6.90	6.34	7.34
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	34	34	34
Total Noncurrent Assets	156	157	154	156	115	112	109
Goodwill	38	40	40	40	40	40	40
Intangible Assets	44	46	44	46	43	42	40
Other Noncurrent Operating Assets	75	71	70	69	31	29	28
Other Noncurrent Nonoperating Assets	0.20	0.52	0.58	0.58	0.58	0.59	0.59
Total Liabilities & Shareholders' Equity	545	528	515	501	452	467	477
Total Liabilities	108	108	110	107	196	202	204
Total Current Liabilities	70	72	74	73	70	78	81
Accounts Payable	11	13	9.88	8.97	9.98	5.87	6.24
Accrued Expenses	45	47	50	47	46	47	45
Current Employee Benefit Liabilities	14	12	14	17	15	25	30
Total Noncurrent Liabilities	38	36	35	34	125	122	121
Noncurrent Deferred & Payable Income Tax Liabilities	0.01	-	0.05	0.14	0.04	0.05	0.20
Other Noncurrent Operating Liabilities	38	36	35	34	125	122	121
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	437	420	405	394	256	265	273
Total Preferred & Common Equity	437	420	405	394	256	265	273
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	437	420	405	394	256	265	273
Common Stock	887	912	924	937	960	969	985
Retained Earnings	-441	-485	-510	-534	-695	-697	-704
Accumulated Other Comprehensive Income / (Loss)	-8.81	-7.44	-8.45	-8.67	-8.11	-7.96	-7.18

This table displays calculated financial ratios and metrics derived from CareDx's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	23.57%	3.07%	44.37%	18.93%	58.45%	65.95%	51.25%	54.22%	8.57%	-12.89%	19.07%
EBITDA Growth	635.41%	-665.72%	-190.47%	-33.17%	26.06%	44.50%	41.10%	-83.58%	-230.66%	-194.21%	132.85%
EBIT Growth	200.29%	-967.57%	-225.92%	-28.97%	23.97%	35.63%	19.70%	-61.07%	-148.07%	-152.53%	120.34%
NOPAT Growth	245.86%	-1,054.56%	-212.87%	45.64%	23.24%	-57.48%	8.17%	-31.95%	-159.81%	-163.32%	128.47%
Net Income Growth	122.05%	-1,855.06%	-190.04%	-39.75%	15.80%	53.04%	14.81%	-63.85%	-149.86%	-148.37%	127.62%
EPS Growth	102.86%	-1,260.00%	-106.03%	0.42%	44.96%	60.31%	23.08%	-47.50%	-144.07%	-145.83%	126.27%
Operating Cash Flow Growth	-513.55%	-191.10%	-69.43%	13.41%	71.99%	30.90%	1,307.33%	-157.71%	-30.81%	27.14%	306.92%
Free Cash Flow Firm Growth	-546.10%	63.97%	-398.86%	128.23%	-485.91%	-15.30%	82.92%	-972.11%	13.02%	59.05%	-69.02%
Invested Capital Growth	411.62%	-5.65%	71.26%	-93.80%	1,808.03%	94.48%	-12.91%	122.33%	17.17%	-81.56%	362.78%
Revenue Q/Q Growth	0.00%	-4.43%	11.56%	3.52%	16.79%	10.73%	6.22%	12.16%	0.99%	-5.66%	6.72%
EBITDA Q/Q Growth	0.00%	-62.11%	-86.67%	-49.56%	47.39%	-23.60%	32.43%	-399.84%	-4.37%	-118.37%	145.42%
EBIT Q/Q Growth	0.00%	-72.13%	-72.26%	-39.46%	43.15%	-21.08%	18.71%	-103.30%	-3.84%	-100.12%	126.49%
NOPAT Q/Q Growth	0.00%	-69.46%	-62.79%	41.80%	10.73%	-14.62%	67.69%	-208.83%	-5.06%	-103.67%	136.98%
Net Income Q/Q Growth	0.00%	-53.13%	-38.02%	-40.15%	37.34%	-4.85%	6.29%	-70.10%	-2.93%	-110.22%	136.60%
EPS Q/Q Growth	0.00%	-397.44%	-6.22%	-46.01%	48.43%	-8.33%	13.04%	-78.79%	-2.13%	-111.98%	134.44%
Operating Cash Flow Q/Q Growth	5.53%	-50.08%	5.25%	5.99%	50.86%	-987.50%	32.84%	-18.52%	10.68%	-551.59%	389.17%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	10.22%	364.04%	-74.68%	-16.53%	83.08%	-144.01%	15.71%	39.32%	-196.21%
Invested Capital Q/Q Growth	0.00%	-1.97%	-35.71%	-92.03%	-0.82%	7.37%	-3.44%	7.84%	-5.44%	-79.80%	253.95%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	68.72%	63.50%	48.02%	55.78%	56.92%	64.23%	67.16%	67.14%	65.13%	63.61%	67.16%
EBITDA Margin	7.25%	-39.82%	-80.12%	-89.71%	-41.86%	-14.00%	-5.45%	-6.49%	-19.76%	-66.75%	18.42%
Operating Margin	4.58%	-42.40%	-91.88%	-42.00%	-20.35%	-19.31%	-11.72%	-10.03%	-24.00%	-72.55%	12.21%
EBIT Margin	5.12%	-43.06%	-97.22%	-105.43%	-50.59%	-19.62%	-10.42%	-10.88%	-24.86%	-72.06%	12.31%
Profit (Net Income) Margin	2.86%	-48.70%	-97.85%	-114.97%	-61.10%	-17.29%	-9.74%	-10.34%	-23.81%	-67.88%	15.74%
Tax Burden Percent	-108.62%	100.00%	96.12%	97.02%	97.03%	91.74%	94.75%	95.56%	100.50%	100.07%	99.41%
Interest Burden Percent	-51.47%	113.09%	104.71%	112.41%	124.48%	96.05%	98.65%	99.50%	95.30%	94.13%	128.63%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.59%
Return on Invested Capital (ROIC)	15.83%	-52.80%	-125.45%	-101.71%	-66.59%	-37.48%	-27.85%	-24.50%	-42.49%	-175.07%	56.87%
ROIC Less NNEP Spread (ROIC-NNEP)	17.10%	-25.45%	233.45%	-687.13%	58.80%	-28.19%	-25.62%	-21.06%	-35.47%	-156.97%	52.04%
Return on Net Nonoperating Assets (RNNOA)	-9.78%	14.08%	-35.98%	-703.10%	-37.40%	14.94%	17.92%	16.25%	25.40%	120.10%	-40.44%
Return on Equity (ROE)	6.05%	-38.72%	-161.43%	-804.81%	-103.99%	-22.54%	-9.94%	-8.25%	-17.09%	-54.98%	16.43%
Cash Return on Invested Capital (CROIC)	-126.72%	-46.98%	-177.99%	74.94%	-246.67%	-101.64%	-14.05%	-100.40%	-58.30%	-37.36%	-72.05%
Operating Return on Assets (OROA)	3.93%	-20.76%	-59.69%	-63.57%	-36.16%	-17.66%	-7.70%	-6.90%	-14.42%	-40.01%	8.58%
Return on Assets (ROA)	2.20%	-23.48%	-60.07%	-69.32%	-43.67%	-15.56%	-7.19%	-6.56%	-13.81%	-37.69%	10.97%
Return on Common Equity (ROCE)	-25.61%	-38.72%	-160.51%	-778.05%	-103.78%	-22.54%	-9.94%	-8.25%	-17.09%	-54.98%	16.43%
Return on Equity Simple (ROE_SIMPLE)	1.89%	-46.47%	-204.07%	905.77%	-48.77%	-22.19%	-6.74%	-6.58%	-17.78%	-72.81%	13.89%
Net Operating Profit after Tax (NOPAT)	0.88	-8.35	-26	-14	-11	-17	-16	-21	-54	-142	41
NOPAT Margin	3.20%	-29.68%	-64.32%	-29.40%	-14.24%	-13.51%	-8.21%	-7.02%	-16.80%	-50.78%	12.14%
Net Nonoperating Expense Percent (NNEP)	-1.27%	-27.35%	-358.89%	585.42%	-125.39%	-9.29%	-2.24%	-3.44%	-7.02%	-18.10%	4.84%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-12.55%	-54.47%	10.71%
Cost of Revenue to Revenue	31.28%	36.50%	51.98%	44.22%	43.08%	35.77%	32.84%	32.86%	34.87%	36.39%	32.84%
SG&A Expenses to Revenue	30.89%	43.52%	51.01%	41.58%	30.01%	28.76%	25.39%	25.29%	31.20%	42.05%	37.08%
R&D to Revenue	14.08%	33.16%	30.48%	25.64%	18.96%	24.17%	25.46%	25.82%	28.09%	29.20%	21.69%
Operating Expenses to Revenue	64.14%	105.89%	139.90%	97.77%	77.26%	83.53%	78.88%	77.17%	89.13%	136.16%	54.94%
Earnings before Interest and Taxes (EBIT)	1.40	-12	-40	-51	-39	-25	-20	-32	-80	-202	41
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1.98	-11	-33	-43	-32	-18	-10	-19	-64	-187	61
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.07	2.58	2.95	0.00	10.20	9.25	12.85	5.15	1.42	2.48	3.03
Price to Tangible Book Value (P/TBV)	3.78	7.03	0.00	0.00	19.30	30.92	17.04	6.34	1.74	3.70	3.83
Price to Revenue (P/Rev)	3.13	2.71	1.41	4.34	12.77	7.20	18.57	8.10	1.90	2.32	3.44
Price to Earnings (P/E)	109.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	21.85
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.91%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	4.58%
Enterprise Value to Invested Capital (EV/IC)	3.72	4.04	2.45	139.32	29.35	14.49	63.45	17.52	2.31	16.34	7.57
Enterprise Value to Revenue (EV/Rev)	2.22	2.20	1.59	4.70	11.93	6.90	17.40	6.93	0.99	1.48	2.66
Enterprise Value to EBITDA (EV/EBITDA)	30.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	14.44
Enterprise Value to EBIT (EV/EBIT)	43.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	21.60
Enterprise Value to NOPAT (EV/NOPAT)	69.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	21.90
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	100.03	0.00	0.00	0.00	23.33
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	21.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.28	0.53	1.21	-5.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.13	0.44	0.06	-3.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.57	-0.55	-0.15	1.02	-0.64	-0.53	-0.70	-0.77	-0.72	-0.77	-0.78
Leverage Ratio	2.75	1.65	2.69	11.61	2.38	1.45	1.38	1.26	1.24	1.46	1.50
Compound Leverage Factor	-1.42	1.87	2.81	13.05	2.96	1.39	1.36	1.25	1.18	1.37	1.93
Debt to Total Capital	21.65%	34.82%	54.79%	121.18%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	11.31%	6.33%	52.27%	55.94%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	10.34%	28.48%	2.51%	65.25%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.64%	0.64%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	78.35%	65.18%	44.58%	-21.83%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	5.76	-1.41	-0.74	-0.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	-12.63	1.26	-0.21	-0.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	2.75	-1.15	-0.03	-0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	13.04	-1.89	-0.92	-2.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	-28.59	1.69	-0.26	-1.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	6.23	-1.54	-0.04	-1.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	0.03	-2.30	-4.66	-4.75	13.71	7.92	23.24	14.44	2.88	-0.36	5.93
Noncontrolling Interest Sharing Ratio	523.49%	0.00%	0.57%	3.32%	0.20%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.62	3.38	0.65	0.62	4.16	2.07	3.95	5.61	5.11	4.02	3.94
Quick Ratio	3.51	3.18	0.49	0.46	3.81	1.79	3.75	5.28	4.73	3.67	3.64
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-21	-7.43	-37	10	-40	-47	-7.95	-85	-74	-30	-51
Operating Cash Flow to CapEx	-457.03%	-813.34%	-3,009.65%	-7,691.94%	-196.90%	-125.81%	470.20%	-142.30%	-118.86%	-220.37%	586.80%
Free Cash Flow to Firm to Interest Expense	-9.75	0.00	0.00	22.80	-6.99	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	-1.58	0.00	0.00	-31.17	-0.69	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-1.93	0.00	0.00	-31.58	-1.05	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.77	0.48	0.61	0.60	0.71	0.90	0.74	0.63	0.58	0.56	0.70
Accounts Receivable Turnover	11.02	11.14	15.83	16.78	12.01	7.52	6.55	6.28	5.10	4.78	5.77
Inventory Turnover	14.19	14.15	6.78	3.89	6.30	8.30	7.88	7.16	6.16	5.27	5.63
Fixed Asset Turnover	15.51	12.81	15.17	19.31	0.00	0.00	0.00	0.00	0.00	0.00	9.70
Accounts Payable Turnover	9.78	7.41	8.97	6.62	8.14	8.90	8.33	8.47	9.64	8.94	10.67
Days Sales Outstanding (DSO)	33.13	32.77	23.06	21.75	30.39	48.57	55.72	58.12	71.50	76.41	63.24
Days Inventory Outstanding (DIO)	25.73	25.79	53.80	93.85	57.94	43.99	46.34	50.97	59.23	69.25	64.88
Days Payable Outstanding (DPO)	37.31	49.24	40.69	55.13	44.82	41.02	43.83	43.08	37.86	40.82	34.22
Cash Conversion Cycle (CCC)	21.55	9.32	36.18	60.47	43.50	51.54	58.23	66.00	92.87	104.84	93.90
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	16	15	26	1.63	31	61	53	117	137	25	117
Invested Capital Turnover	4.94	1.78	1.95	3.46	4.68	2.77	3.39	3.49	2.53	3.45	4.68
Increase / (Decrease) in Invested Capital	22	-0.92	11	-25	29	29	-7.82	64	20	-112	92
Enterprise Value (EV)	61	62	64	227	913	877	3,344	2,053	318	414	888
Market Capitalization	86	76	57	210	978	915	3,569	2,401	611	649	1,148
Book Value per Share	$3.50	$2.48	$0.92	($0.21)	$2.47	$2.33	$5.64	$8.82	$8.05	$4.83	$7.06
Tangible Book Value per Share	$1.92	$0.91	($1.29)	($1.79)	$1.30	$0.70	$4.25	$7.17	$6.54	$3.24	$5.59
Total Capital	53	45	44	28	96	99	278	466	431	261	378
Total Debt	11	16	24	34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	5.45	13	1.10	18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-25	-14	6.69	17	-65	-38	-225	-348	-293	-235	-261
Capital Expenditures (CapEx)	0.73	1.20	0.55	0.19	2.04	2.20	7.11	14	21	8.34	6.48
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-1.26	-2.81	-8.57	-17	-3.01	-1.13	-21	7.57	19	0.22	1.81
Debt-free Net Working Capital (DFNWC)	35	27	8.69	-0.42	62	37	204	356	312	236	262
Net Working Capital (NWC)	29	24	-14	-16	62	37	204	356	312	236	262
Net Nonoperating Expense (NNE)	0.09	5.35	14	41	36	4.80	2.94	9.85	23	48	-12
Net Nonoperating Obligations (NNO)	-25	-14	6.54	7.59	-65	-38	-225	-349	-294	-236	-261
Total Depreciation and Amortization (D&A)	0.58	0.91	6.95	7.60	6.68	7.14	9.54	13	16	15	20
Debt-free, Cash-free Net Working Capital to Revenue	-4.61%	-9.99%	-21.09%	-35.83%	-3.93%	-0.89%	-10.83%	2.56%	5.84%	0.08%	0.54%
Debt-free Net Working Capital to Revenue	128.81%	96.21%	21.38%	-0.87%	80.46%	29.19%	106.08%	120.13%	96.92%	84.06%	78.63%
Net Working Capital to Revenue	106.98%	86.02%	-34.85%	-33.40%	80.46%	29.19%	106.08%	120.13%	96.92%	84.06%	78.63%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.13	($1.16)	($2.39)	($2.38)	($1.31)	($0.52)	($0.40)	($0.59)	($1.44)	($3.54)	$1.00
Adjusted Weighted Average Basic Shares Outstanding	5.82M	11.86M	16.50M	23.33M	35.64M	42.15M	46.48M	52.24M	53.32M	53.76M	52.77M
Adjusted Diluted Earnings per Share	$0.10	($1.16)	($2.39)	($2.38)	($1.31)	($0.52)	($0.40)	($0.59)	($1.44)	($3.54)	$0.93
Adjusted Weighted Average Diluted Shares Outstanding	9.28M	11.86M	16.50M	23.33M	35.64M	42.15M	46.48M	52.24M	53.32M	53.76M	56.62M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	11.81M	11.97M	16.50M	29.07M	41.73M	42.88M	51.82M	53.03M	53.67M	51.78M	55.43M
Normalized Net Operating Profit after Tax (NOPAT)	0.01	-8.44	-17	-13	-11	-17	-16	-21	-54	-73	-53
Normalized NOPAT Margin	0.03%	-29.99%	-42.67%	-26.56%	-14.24%	-13.51%	-8.21%	-7.02%	-16.80%	-26.16%	-16.01%
Pre Tax Income Margin	-2.63%	-48.70%	-101.80%	-118.51%	-62.97%	-18.85%	-10.28%	-10.83%	-23.69%	-67.83%	15.84%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.66	0.00	0.00	-111.00	-6.70	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.41	0.00	0.00	-30.95	-1.89	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.31	0.00	0.00	-111.40	-7.05	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.07	0.00	0.00	-31.35	-2.24	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	477.98%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.84%	-14.47%	0.99%

This table displays calculated financial ratios and metrics derived from CareDx's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	4.99%	3.99%	-2.71%	-12.81%	-15.33%	-20.41%	-6.75%	31.26%	23.35%	32.04%
EBITDA Growth	-49.67%	-19.76%	-36.68%	-34.36%	-75.50%	-628.78%	41.91%	100.53%	78.44%	167.42%
EBIT Growth	-48.17%	-17.35%	-32.46%	-25.50%	-49.39%	-504.67%	25.35%	84.95%	61.82%	162.04%
NOPAT Growth	-98.68%	-24.16%	-27.66%	-27.19%	-66.00%	-541.38%	20.50%	85.17%	63.55%	186.82%
Net Income Growth	-42.38%	-13.49%	-20.87%	-15.01%	-38.64%	-544.32%	29.85%	94.41%	68.46%	166.06%
EPS Growth	-39.13%	-9.68%	-18.92%	-12.20%	-34.38%	-550.00%	27.27%	93.48%	67.44%	164.25%
Operating Cash Flow Growth	-1,953.14%	72.47%	103.13%	87.13%	-43.79%	-216.65%	-2,381.97%	3,897.39%	223.02%	361.17%
Free Cash Flow Firm Growth	19.10%	55.48%	77.08%	90.24%	99.36%	178.00%	732.63%	2,073.64%	27,394.31%	-166.36%
Invested Capital Growth	33.64%	17.17%	-3.29%	-11.06%	-13.66%	-81.56%	-69.25%	-69.80%	-73.59%	362.78%
Revenue Q/Q Growth	-1.58%	3.81%	-6.22%	-9.01%	-4.42%	-2.42%	9.88%	28.07%	-10.18%	4.46%
EBITDA Q/Q Growth	27.24%	-22.95%	-38.24%	-8.65%	4.97%	-410.57%	88.98%	101.00%	-3,948.06%	1,696.70%
EBIT Q/Q Growth	19.47%	-11.90%	-31.28%	-6.09%	4.14%	-352.91%	83.79%	78.61%	-143.19%	835.90%
NOPAT Q/Q Growth	20.17%	-10.27%	-27.22%	-13.57%	-4.20%	-326.06%	84.23%	78.81%	-156.03%	1,114.77%
Net Income Q/Q Growth	21.93%	-8.21%	-29.57%	-5.07%	5.88%	-402.86%	85.89%	91.63%	-431.42%	1,153.05%
EPS Q/Q Growth	21.95%	-6.25%	-29.41%	-4.55%	6.52%	-413.95%	85.52%	90.63%	-366.67%	1,114.29%
Operating Cash Flow Q/Q Growth	-82.59%	201.50%	-90.66%	-174.37%	-1,939.88%	17.66%	-82.70%	223.75%	-33.92%	74.80%
Free Cash Flow Firm Q/Q Growth	-14.03%	31.18%	62.75%	66.61%	92.54%	8,500.39%	202.13%	4.18%	3.23%	-120.42%
Invested Capital Q/Q Growth	5.89%	-5.44%	-2.72%	-8.69%	2.80%	-79.80%	62.17%	-10.32%	-10.10%	253.95%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	64.34%	64.20%	66.39%	63.18%	63.49%	60.94%	64.01%	69.71%	66.73%	67.45%
EBITDA Margin	-16.53%	-19.58%	-28.86%	-34.46%	-34.27%	-179.29%	-17.98%	0.14%	-5.99%	91.55%
Operating Margin	-21.85%	-23.21%	-31.48%	-39.29%	-42.84%	-187.03%	-26.84%	-4.44%	-12.66%	86.27%
EBIT Margin	-22.55%	-24.31%	-34.03%	-39.68%	-39.79%	-184.68%	-27.24%	-4.55%	-12.32%	86.77%
Profit (Net Income) Margin	-21.34%	-22.25%	-30.74%	-35.49%	-34.95%	-180.11%	-23.12%	-1.51%	-8.94%	90.10%
Tax Burden Percent	101.60%	100.95%	100.52%	99.73%	99.66%	100.14%	99.50%	101.60%	102.77%	99.78%
Interest Burden Percent	93.16%	90.66%	89.86%	89.71%	88.14%	97.39%	85.30%	32.68%	70.60%	104.06%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.22%
Return on Invested Capital (ROIC)	-38.39%	-41.09%	-51.86%	-65.68%	-65.86%	-451.35%	-59.19%	-11.63%	-34.98%	403.21%
ROIC Less NNEP Spread (ROIC-NNEP)	-36.93%	-39.55%	-49.64%	-63.77%	-64.67%	-439.16%	-57.95%	-12.21%	-34.95%	401.81%
Return on Net Nonoperating Assets (RNNOA)	26.61%	28.32%	34.27%	44.31%	43.61%	335.99%	42.98%	9.32%	26.65%	-312.30%
Return on Equity (ROE)	-11.78%	-12.76%	-17.59%	-21.37%	-22.25%	-115.35%	-16.21%	-2.32%	-8.32%	90.91%
Cash Return on Invested Capital (CROIC)	-69.33%	-58.30%	-39.17%	-36.06%	-37.00%	-37.36%	-53.11%	-46.94%	-21.88%	-72.05%
Operating Return on Assets (OROA)	-12.97%	-14.10%	-20.24%	-23.24%	-22.61%	-102.53%	-15.28%	-2.75%	-7.88%	60.48%
Return on Assets (ROA)	-12.28%	-12.90%	-18.28%	-20.79%	-19.86%	-100.00%	-12.97%	-0.91%	-5.72%	62.80%
Return on Common Equity (ROCE)	-11.78%	-12.76%	-17.59%	-21.37%	-22.25%	-115.35%	-16.21%	-2.32%	-8.32%	90.91%
Return on Equity Simple (ROE_SIMPLE)	-17.05%	0.00%	-19.22%	-20.72%	-22.97%	0.00%	-71.50%	-60.32%	-52.54%	0.00%
Net Operating Profit after Tax (NOPAT)	-12	-13	-17	-19	-20	-86	-14	-2.87	-7.34	75
NOPAT Margin	-15.29%	-16.25%	-22.04%	-27.51%	-29.99%	-130.92%	-18.79%	-3.11%	-8.86%	86.08%
Net Nonoperating Expense Percent (NNEP)	-1.47%	-1.54%	-2.22%	-1.90%	-1.19%	-12.18%	-1.25%	0.58%	-0.03%	1.40%
Return On Investment Capital (ROIC_SIMPLE)	-	-3.11%	-	-	-	-32.85%	-	-	-	19.69%
Cost of Revenue to Revenue	35.66%	35.80%	33.61%	36.82%	36.51%	39.06%	35.99%	30.29%	33.27%	32.55%
SG&A Expenses to Revenue	30.03%	30.07%	36.28%	41.72%	50.55%	40.48%	37.35%	30.00%	34.40%	46.99%
R&D to Revenue	28.11%	28.61%	31.53%	28.78%	28.28%	27.87%	25.97%	21.33%	21.10%	19.09%
Operating Expenses to Revenue	86.19%	87.41%	97.87%	102.47%	106.33%	247.96%	90.84%	74.16%	79.39%	-18.82%
Earnings before Interest and Taxes (EBIT)	-18	-20	-26	-28	-27	-121	-20	-4.20	-10	75
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-13	-16	-22	-24	-23	-118	-13	0.13	-4.96	79
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.08	1.42	1.17	1.13	0.96	2.48	2.14	3.06	6.03	3.03
Price to Tangible Book Value (P/TBV)	2.56	1.74	1.47	1.42	1.23	3.70	3.18	4.43	8.55	3.83
Price to Revenue (P/Rev)	2.86	1.90	1.53	1.48	1.28	2.32	1.99	2.72	5.27	3.44
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	21.85
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	4.58%
Enterprise Value to Invested Capital (EV/IC)	4.26	2.31	1.53	1.43	0.89	16.34	8.09	15.75	42.46	7.57
Enterprise Value to Revenue (EV/Rev)	1.94	0.99	0.64	0.56	0.37	1.48	1.21	1.95	4.50	2.66
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	14.44
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	21.60
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	21.90
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	627.94	0.00	0.00	0.00	0.00	180.76	23.33
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.72	-0.72	-0.69	-0.69	-0.67	-0.77	-0.74	-0.76	-0.76	-0.78
Leverage Ratio	1.22	1.24	1.22	1.24	1.26	1.46	1.45	1.47	1.47	1.50
Compound Leverage Factor	1.14	1.12	1.10	1.12	1.11	1.42	1.24	0.48	1.03	1.56
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	5.10	3.24	2.56	2.21	1.70	0.21	0.61	1.54	4.00	6.16
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	5.52	5.11	5.17	4.84	4.75	4.02	4.32	4.09	4.10	3.94
Quick Ratio	5.15	4.73	4.81	4.49	4.40	3.67	3.93	3.77	3.78	3.64
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-49	-34	-12	-4.17	-0.31	26	79	82	85	-17
Operating Cash Flow to CapEx	-146.08%	219.26%	24.22%	-21.13%	-629.50%	-525.78%	-1,029.72%	1,058.60%	743.15%	1,438.17%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.58	0.58	0.59	0.59	0.57	0.56	0.56	0.61	0.64	0.70
Accounts Receivable Turnover	5.03	5.10	5.13	5.08	4.87	4.78	4.61	5.04	5.29	5.77
Inventory Turnover	5.95	6.16	6.14	5.82	5.87	5.27	5.35	5.46	5.75	5.63
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	9.70
Accounts Payable Turnover	8.60	9.64	9.49	8.19	10.81	8.94	8.93	13.21	14.08	10.67
Days Sales Outstanding (DSO)	72.52	71.50	71.16	71.85	75.00	76.41	79.25	72.36	69.04	63.24
Days Inventory Outstanding (DIO)	61.35	59.23	59.41	62.75	62.16	69.25	68.28	66.80	63.48	64.88
Days Payable Outstanding (DPO)	42.45	37.86	38.48	44.56	33.78	40.82	40.87	27.64	25.93	34.22
Cash Conversion Cycle (CCC)	91.42	92.87	92.09	90.04	103.39	104.84	106.65	111.51	106.59	93.90
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	145	137	134	122	125	25	41	37	33	117
Invested Capital Turnover	2.51	2.53	2.35	2.39	2.20	3.45	3.15	3.74	3.95	4.68
Increase / (Decrease) in Invested Capital	37	20	-4.55	-15	-20	-112	-92	-85	-92	92
Enterprise Value (EV)	619	318	205	175	111	414	332	580	1,406	888
Market Capitalization	910	611	491	457	379	649	548	809	1,647	1,148
Book Value per Share	$8.17	$8.05	$7.83	$7.53	$7.28	$4.83	$4.95	$5.08	$5.18	$7.06
Tangible Book Value per Share	$6.65	$6.54	$6.24	$5.99	$5.68	$3.24	$3.33	$3.50	$3.65	$5.59
Total Capital	437	431	420	405	394	261	256	265	273	378
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-291	-293	-286	-283	-268	-235	-216	-229	-241	-261
Capital Expenditures (CapEx)	4.85	3.28	2.77	2.36	1.62	1.59	1.49	1.79	1.69	1.52
Debt-free, Cash-free Net Working Capital (DFCFNWC)	27	19	14	3.65	4.31	0.22	17	13	12	1.81
Debt-free Net Working Capital (DFNWC)	318	312	300	286	272	236	233	242	253	262
Net Working Capital (NWC)	318	312	300	286	272	236	233	242	253	262
Net Nonoperating Expense (NNE)	4.80	4.95	6.72	5.62	3.34	32	3.12	-1.47	0.06	-3.48
Net Nonoperating Obligations (NNO)	-291	-294	-286	-283	-269	-236	-215	-228	-240	-261
Total Depreciation and Amortization (D&A)	4.78	3.90	3.99	3.66	3.71	3.53	6.67	4.33	5.25	4.13
Debt-free, Cash-free Net Working Capital to Revenue	8.35%	5.84%	4.27%	1.18%	1.45%	0.08%	6.17%	4.51%	3.77%	0.54%
Debt-free Net Working Capital to Revenue	99.76%	96.92%	93.73%	92.57%	91.71%	84.06%	84.65%	81.55%	80.78%	78.63%
Net Working Capital to Revenue	99.76%	96.92%	93.73%	92.57%	91.71%	84.06%	84.65%	81.55%	80.78%	78.63%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.32)	($0.34)	($0.44)	($0.46)	($0.43)	($2.21)	($0.32)	($0.03)	($0.14)	$1.49
Adjusted Weighted Average Basic Shares Outstanding	53.49M	53.32M	53.64M	53.85M	54.18M	53.76M	51.69M	52.20M	52.90M	52.77M
Adjusted Diluted Earnings per Share	($0.32)	($0.34)	($0.44)	($0.46)	($0.43)	($2.21)	($0.32)	($0.03)	($0.14)	$1.42
Adjusted Weighted Average Diluted Shares Outstanding	53.49M	53.32M	53.64M	53.85M	54.18M	53.76M	51.69M	52.20M	52.90M	56.62M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	53.54M	53.67M	53.79M	54.17M	54.10M	51.78M	52.08M	52.74M	53.63M	55.43M
Normalized Net Operating Profit after Tax (NOPAT)	-12	-13	-17	-19	-20	-86	-14	-2.82	-7.34	75
Normalized NOPAT Margin	-15.29%	-16.25%	-22.04%	-26.66%	-29.99%	-130.92%	-18.79%	-3.06%	-8.86%	86.08%
Pre Tax Income Margin	-21.01%	-22.04%	-30.58%	-35.59%	-35.07%	-179.86%	-23.24%	-1.49%	-8.70%	90.30%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	-0.84%	-1.65%	-1.67%	-2.44%	-14.47%	-14.94%	-17.11%	-18.45%	0.99%

Frequently Asked Questions About CareDx's Financials

When does CareDx's financial year end?

According to the most recent income statement we have on file, CareDx's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has CareDx's net income changed over the last 10 years?

CareDx's net income appears to be on an upward trend, with a most recent value of $52.55 million in 2024, rising from $781 thousand in 2014. The previous period was -$190.28 million in 2023.

What is CareDx's operating income?

CareDx's total operating income in 2024 was $40.77 million, based on the following breakdown:

Total Gross Profit: $224.16 million
Total Operating Expenses: $183.39 million

How has CareDx revenue changed over the last 10 years?

Over the last 10 years, CareDx's total revenue changed from $27.31 million in 2014 to $333.79 million in 2024, a change of 1,122.4%.

How much debt does CareDx have?

CareDx's total liabilities were at $112.62 million at the end of 2024, a 45.2% decrease from 2023, and a 467.5% increase since 2014.

How much cash does CareDx have?

In the past 10 years, CareDx's cash and equivalents has ranged from $16.90 million in 2017 to $348.49 million in 2021, and is currently $114.69 million as of their latest financial filing in 2024.

How has CareDx's book value per share changed over the last 10 years?

Over the last 10 years, CareDx's book value per share changed from 3.50 in 2014 to 7.06 in 2024, a change of 101.7%.

Remove Ads

Related Companies

This page (NASDAQ:CDNA) was last updated on 4/16/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CareDx (CDNA) Financials

Frequently Asked Questions About CareDx's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CareDx (CDNA) Financials

Annual Income Statements for CareDx

Quarterly Income Statements for CareDx

Annual Cash Flow Statements for CareDx

Quarterly Cash Flow Statements for CareDx

Annual Balance Sheets for CareDx

Quarterly Balance Sheets for CareDx

Annual Metrics and Ratios for CareDx

Quarterly Metrics and Ratios for CareDx

Frequently Asked Questions About CareDx's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools